Express Pharma

Sanofi Pasteur launches 6-in-1 paediatric vaccine, Hexaxim


The vaccine provides protection against six major childhood diseases

Sanofi Pasteur, the vaccines global business unit of Sanofi, has launched India’s first innovative ready-to-use fully liquid 6-in-1 vaccine – Hexaxim. The vaccine, indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age, provides protection against six major childhood diseases – diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenza B and hepatitis B.

The burden of the six diseases is significant, particularly in infants. Consequently, the WHO and the wide majority of countries around the world recommend vaccination against these diseases. India, under the Universal Immunization Programme, also offers protection against these six major diseases.

Globally, Hexaxim is the only combination vaccine with acellular pertussis (acP) and inactivated poliovirus vaccine (IPV) to have received a prequalification by the WHO. Today, the vaccine protects infants in more than 60 countries, with 20+ million doses distributed worldwide.

Jean-Pierre Baylet, Country Head – Sanofi Pasteur India, Nepal and Sri Lanka, said, “Given the large influx of patients met by pediatricians in India, Hexaxim will offer convenience and ensure consistency in administering the right dose of each antigen every single time. At Sanofi Pasteur, with every new vaccine we launch, our aim is to raise the bar of care in vaccination of children.”

EP News Bureau


Comments are closed.